Authors:
Cardoen, S
Van den Neste, E
Smal, C
Rosier, JF
Delacauw, A
Ferrant, A
Van den Berghe, G
Bontemps, F
Citation: S. Cardoen et al., Resistance to 2-chloro-2 '-deoxyadenosine of the human B-cell leukemia cell line EHEB, CLIN CANC R, 7(11), 2001, pp. 3559-3566
Authors:
Van den Neste, E
Delannoy, A
Feremans, W
Ferrant, A
Michaux, L
Citation: E. Van Den Neste et al., Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment, LEUK LYMPH, 40(5-6), 2001, pp. 541-550
Authors:
Van den Neste, E
de Valeriola, D
Kerger, J
Bleiberg, H
Kusenda, Z
Brassinne, C
Bartholomeus, S
Selleslags, J
Hennebert, P
Wythouck, H
Cazenave, I
Lefresne-Soulas, F
Piccart, M
Citation: E. Van Den Neste et al., A Phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors, CLIN CANC R, 6(1), 2000, pp. 64-71
Authors:
Van den Neste, E
Louviaux, I
Michaux, JL
Delannoy, A
Michaux, L
Sonet, A
Bosly, A
Doyen, C
Mineur, P
Andre, M
Straetmans, N
Coche, E
Venet, C
Duprez, T
Ferrant, A
Citation: E. Van Den Neste et al., Phase I/II study of 2-chloro-2 '-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent. non-Hodgkin's lymphoma, LEUKEMIA, 14(6), 2000, pp. 1136-1142
Authors:
Bontemps, F
Delacauw, A
Cardoen, S
Van den Neste, E
Van den Berghe, G
Citation: F. Bontemps et al., Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2 '-deoxyadenosine, BIOCH PHARM, 59(10), 2000, pp. 1237-1243